- Expires: June 14, 2025
- Credit: 1.0hr(s)
- ILNA, NCPD
- Therapeutic Areas: Chronic Lympoblastic Leukemia (CLL), Hematologic Oncology, Hematology, Oncology
- Specialties: Myelofibrosis
In this first episode, “Making the Right Selection: Expert Guidance on Treatment Sequencing of T-cell Mediated Therapies,” from the 4-part series Med Table Talk, “The Power of the Community: Translating Innovations into Care in NHL and HL,” learn from expert faculty about unmet needs for patients with NHL based on an understanding of disease- and patient-related characteristics. Additionally, learn how to best assess eligible patients among new and emerging CAR T-cell and bispecific antibody therapies. Expert faculty will also discuss both the mechanisms of action of CAR T-cell and bispecific antibodies. This episode will conclude with a patient case study, which will consist of a dialogue between faculty.